Loading publications…
The last 5 uploaded publications
Homeostatic defects in interleukin 18‐deficient mice contribute to protection against the lethal effects of endotoxin
Daniel M. Andrews, Melvyn T. Chow, Yuting Ma, Claire L Cotterell, Sally V. Watt, Desiree A. Anthony, Akira Shizuo, Yoichiro Iwakura, Joseph A. Trapani, Laurence Zitvogel, Mark J. Smyth (2011). Homeostatic defects in interleukin 18‐deficient mice contribute to protection against the lethal effects of endotoxin. Immunology and Cell Biology, 89(6), pp. 739-746, DOI: 10.1038/icb.2010.168.
Article167 days agoGut microbiota modulation through Akkermansia spp. supplementation increases CAR-T cell potency
Laura Marcos-Kovandzic, Michele Avagliano, Myriam Ben Khelil, Janesa Srikanthan, Rim ABDALLAH, Valentina Petrocelli, Jessica Rengassamy, Alexia Alfaro, Mathilde Bied, Marine Fidelle, Gladys Ferrere, Romain Daillère, Ahmadreza Arbab, Roula Amine-Hneineh, Arnaud Pagès, Peggy Dartigues, Pierre Ly, Sylvain Simon, Sylvère Durand, Adrian Gottschlich, Florent Ginhoux, Camille Blériot, Peng Liu, Liwei Zhao, Laura Creusot, Nathalie Rolhion, Guido Kroemer, Laurie Menger, Sebastian Kobold, Cristina Castilla‐Llorente, Harry Sokol, Stefano Casola, Edoardo Pasolli, Laurence Zitvogel, Camille Bigenwald (2025). Gut microbiota modulation through Akkermansia spp. supplementation increases CAR-T cell potency. , DOI: https://doi.org/10.1158/2159-8290.cd-24-1230.
Article73 days agoMetabolites as agents and targets for cancer immunotherapy
Marcel P. Trefny, Guido Guido Kroemer, Laurence Zitvogel, Sebastian Kobold (2025). Metabolites as agents and targets for cancer immunotherapy . , DOI: https://doi.org/10.1038/s41573-025-01227-z.
Article72 days agoThe microbiota in radiotherapy-induced cancer immunosurveillance
Jianzhou Chen, Éric Deutsch, Guido Guido Kroemer, Lorenzo Galluzzi, Laurence Zitvogel (2025). The microbiota in radiotherapy-induced cancer immunosurveillance. , DOI: https://doi.org/10.1038/s41571-025-01052-8.
Article72 days agoAbstract 2210: Microbiome profiling reveals that fecal microbiota transplantation (FMT) modulates response and toxicity when combined with immunotherapy in patients with lung cancer and melanoma (FMT-LUMINate NCT04951583)
Sreya Duttagupta, Meriem Messaoudene, Rahima Jamal, Catalin Mihalcioiu, Nicolas Marcoux, Sebastian Hunter, Gianmarco Piccinno, Michal Punčochář, Karl Bélanger, Mustapha Tehfé, Normand Blais, Scott Owen, Jacques Raphael, Jade Maillou, Yongjia Hu, Myriam Benlaïfaoui, Somayeh Nilli, John Lenehan, Wiam Belkaïd, Seema Nair Parvathy, Diogjena Katerina Prifti, Marine Fidelle, Seunghee Kim‐Schulze, Thomas U. Marron, Sylvère Durand, Guido Guido Kroemer, Nicola Segata, Lisa Derosa, Laurence Zitvogel, Antoine Desîlets, Michael E. Silverman, Saman MalekiVareki, Bertrand Routy, Arielle Elkrief (2025). Abstract 2210: Microbiome profiling reveals that fecal microbiota transplantation (FMT) modulates response and toxicity when combined with immunotherapy in patients with lung cancer and melanoma (FMT-LUMINate NCT04951583). , 85(8_Supplement_1), DOI: https://doi.org/10.1158/1538-7445.am2025-2210.
Article72 days ago